(Q50457694)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

5

Jos H Beijnen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

6

Jan H M Schellens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Kim D Mooiman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Tomy J Huijbregts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Roel F Maas-Bakker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Irma Meijerman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

15 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

1339-1346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

Cytochromes P450 and metabolism of xenobiotics

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Complementary and alternative medicine during cancer treatment: beyond innocence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Effects of herbal products on the metabolism and transport of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Potential health risks of complementary alternative medicines in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Herbal remedies in the United States: potential adverse interactions with anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Inhibition of human cytochromes P450 by components of Ginkgo biloba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Milk thistle's active components silybin and isosilybin: novel inhibitors of PXR-mediated CYP3A4 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Influence of fluorescent probe size and cytochrome b5 on drug-drug interactions in CYP2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Effects of repeated green tea catechin administration on human cytochrome P450 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12259

21 January 2018

Identifiers

DOI

10.1111/JPHP.12259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24730468%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference